Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

WHOLE BODY SCANNING IN MEDICINE. II. CLINICAL ASPECTS

Journal Article · · Canadian Medical Association Journal (Canada)
OSTI ID:4751339
Whole-body scans were conducted in 439 patients using I/sup 131/, Fe/sup 59/, Cu/sup 64/, Sr/sup 85/, /Ca/sup 47/, or I/sup 131/-label ed 5- iododexyuridine. With I/sup 131/, functioning metastases were demonstrated in 11 of 26 patients with follicular or papillary thyroid cancer. Fe/sup 59/ scans demonstiatecl extramedullary, hematopoiesis in patients with polycythemia vera, myelofibrosis, and myelophthisic anemia. Cu/sup 64/ studies showed abnormal concentration in the kidneys in 2 patients with Wilson's disease. Sr/sup 85/ localized in bone metastases in at least 4 patients with malignant disease. Liver and kidney scans, using I/sup 131/-Rose Bengal and Hg/sup 203/-Neohydrin respectively, were useful in the management of patients suffering from malignant disease, renal hypertension, and certain other disorders. Results with the total- body scanner shows that it plays a valuable role in the investigation and management of patients with malignant disease. Its usefulness will increase with the finding of suitable labeled substances possessing a marked affinity for certain organs or tumor tissues. (H.H.D.)
Research Organization:
Univ. of Toronto
NSA Number:
NSA-17-005806
OSTI ID:
4751339
Journal Information:
Canadian Medical Association Journal (Canada), Journal Name: Canadian Medical Association Journal (Canada) Vol. Vol: 87; ISSN CMAJA
Country of Publication:
Country unknown/Code not available
Language:
English